Routine Gene Testing For Plavix Patients Unsupported By Evidence - ACC/AHA

The evidence base is insufficient to support routine genetic or platelet function testing to assess a patient's responsiveness to the anti-clotting drug clopidogrel, according to new cardiovascular society guidelines

More from Archive

More from Medtech Insight